Nasmed Ozel Saglik Hizmetleri Ticaret AS
IST:EGEPO.E

Watchlist Manager
Nasmed Ozel Saglik Hizmetleri Ticaret AS Logo
Nasmed Ozel Saglik Hizmetleri Ticaret AS
IST:EGEPO.E
Watchlist
Price: 7.19 TRY -1.91% Market Closed
Market Cap: 3.6B TRY
Section:
 

Relative Value

The Relative Value of one EGEPO.E stock under the Base Case scenario is 3.2 TRY. Compared to the current market price of 7.19 TRY, Nasmed Ozel Saglik Hizmetleri Ticaret AS is Overvalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EGEPO.E Relative Value
Base Case
3.2 TRY
Overvaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
11
vs Industry
62
Median 3Y
1.6
Median 5Y
1.4
Industry
2.3
More Details
3 423.8
P/E
P/E
Price to Earnings
3 423.8
vs History
11
vs Industry
44
Median 3Y
-2.3
Median 5Y
5
Industry
22.4
More Details
37.1
P/OCF
P/OCF
Price to OCF
37.1
vs History
33
vs Industry
42
Median 3Y
18.1
Median 5Y
8.5
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-17
Median 5Y
-4.5
Industry
21.5
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
18
vs Industry
72
Median 3Y
1.6
Median 5Y
1.1
Industry
2.2
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
11
vs Industry
64
Median 3Y
1.7
Median 5Y
1.3
Industry
2.5
More Details
16
EV/GP
EV/GP
Enterprise Value to Gross Profit
16
vs History
11
vs Industry
50
Median 3Y
6.4
Median 5Y
5.7
Industry
5.1
More Details
67
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
67
vs History
13
vs Industry
44
Median 3Y
15.8
Median 5Y
9.7
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
20
Median 3Y
9
Median 5Y
9
Industry
17.1
More Details
37.6
EV/OCF
EV/OCF
Enterprise Value to OCF
37.6
vs History
32
vs Industry
42
Median 3Y
18.4
Median 5Y
7.6
Industry
14.7
More Details
107.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
107.2
vs History
11
vs Industry
Median 3Y
8.2
Median 5Y
-2.1
Industry
18.8
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
15
vs Industry
73
Median 3Y
1.5
Median 5Y
1
Industry
1.8
More Details

Multiples Across Competitors

EGEPO.E Competitors Multiples
Nasmed Ozel Saglik Hizmetleri Ticaret AS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TR
Nasmed Ozel Saglik Hizmetleri Ticaret AS
IST:EGEPO.E
3.6B TRY 3.2 3 423.8 67 -45.8
US
HCA Healthcare Inc
NYSE:HCA
107.1B USD 1.4 16.9 9.6 12.4
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 7.5 41.5 32.9 40.9
ZA
Netcare Ltd
JSE:NTC
20.5B Zac 0 0 0 0
MY
IHH Healthcare Bhd
KLSE:IHH
75.7B MYR 2.9 32.8 14.2 20.9
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
101.9B BRL 1.9 24.8 9.4 11.3
US
Tenet Healthcare Corp
NYSE:THC
17.1B USD 0.8 12.6 6.1 7.5
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
16.5B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
104.8B CNY 4.7 32.6 23.4 23.4
US
Universal Health Services Inc
NYSE:UHS
14B USD 0.8 10.1 7 9.1
ID
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
201.9T IDR 75 -1 679.8 1 636.1 1 636.1

See Also

Summary
EGEPO.E intrinsic value, competitors valuation, and company profile.
DCF Valuation
EGEPO.E stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EGEPO.E stock valuation using valuation multiples.
Wall Street Estimates
EGEPO.E price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EGEPO.E stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.